Multiple Sclerosis Spasticity clinical trials

Explore recruiting multiple sclerosis spasticity clinical trials.

Recruiting multiple sclerosis spasticity studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Multiple Sclerosis Spasticity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Randomized, Double-Blind, Four-Arm, Placebo-Controlled, Multicenter Study Assessing the Efficacy, Safety and Tolerability of three doses of orally administered BMS-986368, a FAAH/MAGL Inhibitor, for the treatment of Spasticity in Participants with Multiple Sclerosis (BALANCE-MSS-1)

Germany, Czechia, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-Label, Single-Arm 4-Year Study to Evaluate Effectiveness and Safety of Ocrelizumab Treatment in Patients with Progressive Multiple Sclerosis

Netherlands, Germany, Denmark, Poland, Czechia, France +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Multiple Sclerosis Spasticity trials by city

Multiple Sclerosis Spasticity in Toronto Multiple Sclerosis Spasticity in Vancouver Multiple Sclerosis Spasticity in Montreal Multiple Sclerosis Spasticity in Calgary Multiple Sclerosis Spasticity in Edmonton Multiple Sclerosis Spasticity in Ottawa Multiple Sclerosis Spasticity in Winnipeg Multiple Sclerosis Spasticity in Quebec City Multiple Sclerosis Spasticity in Hamilton Multiple Sclerosis Spasticity in Kitchener Multiple Sclerosis Spasticity in London Multiple Sclerosis Spasticity in Halifax Multiple Sclerosis Spasticity in New York Multiple Sclerosis Spasticity in Los Angeles Multiple Sclerosis Spasticity in Chicago Multiple Sclerosis Spasticity in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease